Skip to main content
. 2015 Jan 14;30(5):641–650. doi: 10.1007/s11606-014-3162-9

Table 4.

Number of SEER-CAHPS Respondents by First Cancer Site and Date of Diagnosis: Fee-for-Service

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 11,341 1624 14.3 1728 15.2 2348 20.7 3252 28.7 2389 21.1
Breast 10,950 1210 11.1 1240 11.3 1848 16.9 2725 24.9 3927 35.9
Colorectal 5784 995 17.2 868 15.0 1010 17.5 1303 22.5 1608 27.8
Lung and Bronchial 3137 1537 49.0 573 18.3 392 12.5 356 11.3 279 8.9
Ovary 631 127 20.1 79 12.5 95 15.1 125 19.8 205 32.5
Uterine Corpus 2164 220 10.2 208 9.6 269 12.4 451 20.8 1016 47.0
Uterine Cervix 848 15 1.8 19 2.2 35 4.1 91 10.7 688 81.1
Bladder 2584 508 19.7 399 15.4 439 17.0 563 21.8 675 26.1
Melanoma 2945 472 16.0 409 13.9 535 18.2 673 22.9 856 29.1
Head and Neck 2525 483 19.1 344 13.6 449 17.8 497 19.7 752 29.8
Kidney and Renal Pelvis 1121 265 23.6 179 16.0 197 17.6 236 21.1 244 21.8
Non-Hodgkin Lymphomas 1608 354 22.0 281 17.5 323 20.1 341 21.2 309 19.2
Leukemia 881 262 29.7 148 16.8 147 16.7 172 19.5 152 17.3
Stomach 416 155 37.3 62 14.9 60 14.4 73 17.5 66 15.9
Esophagus 188 97 51.6 35 18.6 18 9.6 24 12.8 14 7.4
Pancreas 385 281 73.0 53 13.8 19 4.9 16 4.2 16 4.2
Liver and Intrahepatic Bile Duct 167 100 59.9 25 15.0 25 15.0 11 6.6 6 3.6
Simultaneous cancers* 654 162 24.8 115 17.6 108 16.5 138 21.1 131 20.0
Other 2959 919 31.1 473 16.0 446 15.1 483 16.3 638 21.6

* Time points for simultaneous cancers refer to the first cancer diagnosis